CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
SmartInhaler with reminder function turned on +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02999789
NCT02999789N/ACompleted

Interventions to Help Asthma Clinical Adherence

University of California, San Francisco·interventional·Posted Dec 21, 2016·Updated Apr 18, 2023

In Brief

A clinical study evaluating SmartInhaler with reminder function turned on and SmartInhaler for Asthma in Children and 3 related conditions. Completed, enrolled 13 participants across 1 site.

Detailed Summary

To conduct a pilot test to estimate the effect of a novel reminder system in improving daily asthma controller medication adherence rates in children with monolingual Spanish-speaking guardians who have limited English Proficiency (LEP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 21, 2016
Enrollment StartJan 1, 2017
Primary CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 9.5 years ago

Interventions

SmartInhaler with reminder function turned ondevice

The SmartInhaler is a medication monitoring system that functions as a patient reminder device. It monitors asthma medication adherence and also functions by providing an audiovisual reminder.

SmartInhalerdevice

The SmartInhaler is a medication monitoring system manufactured by Adherium that also functions as a patient reminder device. It monitors asthma medication adherence and also functions by providing an audiovisual reminder.